<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00825279</url>
  </required_header>
  <id_info>
    <org_study_id>02-CECI</org_study_id>
    <secondary_id>02-CECI</secondary_id>
    <secondary_id>IMA 01</secondary_id>
    <nct_id>NCT00825279</nct_id>
  </id_info>
  <brief_title>A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent</brief_title>
  <acronym>EUCATAX</acronym>
  <official_title>Comparison Among a Paclitaxel Eluting Stent With Biodegradable Polymer Versus an Uncoated Bare Metal Stent. A Prospective, Multicentric and Randomized Study.(EUCATAX Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de estudios en Cardiologia Intervencionista</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eucatech AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro de estudios en Cardiologia Intervencionista</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The success of stent implantation has led to the increasingly widespread use of them in the
      treatment of coronary artery disease (Sigwart, Serruys, Fischman)and although stent
      restenosis is still a limit for this therapeutic mode (Serruys, Rodriguez) the new generation
      of stents with improved coating materials and the development of polymers that release
      different kinds of drugs that prevent the activation and/or proliferation of smooth muscle
      cells (ultimate cause of restenosis) (Grube, Rodriguez). shows major improvements on this
      matter. The new generation of stents with biodegradable polymers and short time of drug
      release gives new advantages to this therapeutic, multiple studies and registries challenge
      this new devices (Taxus I and II, RAVEL, SIRIUS, ERACI II and III).

      For this reason the present study aims to compare a stainless steel stent with a drug eluting
      stent with coated of biodegradable polymer matrix hemoparin and paclitaxel.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with de novo lesions treated in different Institutions in Buenos Aires Argentina
      were randomized to treat with a stainless steel stent (&quot;euca STS Flex&quot;) or a drug-eluting
      stent (&quot; euca STS Flex DE&quot;) with a coating of a biodegradable polymer matrix of hemoparin and
      paclitaxel.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target Vessel Failure</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paclitaxel allergy</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1-BMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bare Metal Stent (Euca STS Flex)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2-DES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug Eluting Stent (Euca STS Flex DE), Paclitaxel Eluting stent with biodegradable polymer</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bare Metal Stent</intervention_name>
    <description>Stainless steel stent</description>
    <arm_group_label>1-BMS</arm_group_label>
    <other_name>Euca STS Flex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug Eluting Stent</intervention_name>
    <description>stent coated with the biodegradable polymer matrix hemoparin and paclitaxel</description>
    <arm_group_label>2-DES</arm_group_label>
    <other_name>Euca STS Flex DE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient signing informed consent after receiving extensive written and oral
             information about the trial,

          -  Older than 18 years,

          -  Agreement to have a control examination done after six months,

          -  Patients with angina pectoris symptoms (CCS stages i-IV, unstable angina pectoris
             Braunwald B and C) and patients with documented silent ischemia;

          -  Patients with one or more de novo lesions which all are to be dilated in the same
             session;

          -  Target vessel diameter of 2.5 to 4.0 mm

        Exclusion Criteria:

          -  Female patients of child bearing age with pregnancy suspicion(a pregnancy test will be
             done in this cases)

          -  Acute myocardial infarction (Q wave or non Q wave ) with documented CK levels more
             than 2 fold higher than the normal values in the preceding 72 hours ,

          -  Substantially calcified lesion precluding successful pre dilatation,

          -  Ejection Fraction less than 35%,

          -  Patient with previous PCI with one DES,

          -  Target lesion &lt; 2.5 mm

          -  Coagulopathy or clotting disorders, leucopenia anemia or thrombocytopenia,

          -  Allergy, hypersensitivity or adverse reaction to paclitaxel,

          -  Intolerance to the clopidogrel, Ticlopidine or Aspirin or unable to receive
             clopidogrel for one year,

          -  Active duodenal or gastric ulcer,

          -  Life Expectancy less than 1 year,

          -  Patient with LM disease (&gt;50%)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfredo E Rodriguez, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Centro de estudios en Cardiologia Intervencionista</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Fernandez-Pereira, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centro de estudios en Cardiologia Intervencionista</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfredo E Rodriguez, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro de Estudios en Cardiologia Internvencionista</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica IMA</name>
      <address>
        <city>Adrogue</city>
        <state>Buenos Aires</state>
        <zip>1846</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Otamendi y Miroli</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1115</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <link>
    <url>http://www.dgk.org</url>
    <description>German Cardiac Society</description>
  </link>
  <link>
    <url>http://www.centroceci.com.ar</url>
    <description>Centro de Estudios en Cardiologia Intervencionista</description>
  </link>
  <reference>
    <citation>Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987 Mar 19;316(12):701-6.</citation>
    <PMID>2950322</PMID>
  </reference>
  <reference>
    <citation>Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489-95.</citation>
    <PMID>8041413</PMID>
  </reference>
  <reference>
    <citation>Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Sch√∂nberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA; Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001 Apr 12;344(15):1117-24.</citation>
    <PMID>11297702</PMID>
  </reference>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2009</study_first_submitted>
  <study_first_submitted_qc>January 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2009</study_first_posted>
  <last_update_submitted>May 27, 2010</last_update_submitted>
  <last_update_submitted_qc>May 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alfredo E Rodriguez, MD, PHD, FACC, FSCAI</name_title>
    <organization>Centro de Estudios en Cardiologia Intervencionista</organization>
  </responsible_party>
  <keyword>Biodegradable polymer</keyword>
  <keyword>Drug Eluting Stent</keyword>
  <keyword>In stent restenosis</keyword>
  <keyword>stent thrombosis</keyword>
  <keyword>Bare Metal Stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

